MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer

被引:35
|
作者
Sun, Z. [1 ,2 ]
Zhou, N. [1 ,2 ]
Han, Q. [3 ]
Zhao, L. [1 ,2 ]
Bai, C. [1 ,2 ]
Chen, Y. [2 ,4 ]
Zhou, J. [1 ,2 ]
Zhao, R. C. [3 ,5 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Oncol, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing 100730, Peoples R China
[4] Chinese Acad Med Sci, Dept Digest, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[5] Peking Union Med Coll Hosp, Ctr Translat Med, Beijing, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2015年 / 17卷 / 11期
基金
中国国家自然科学基金;
关键词
miR-197; 5-Fluorouracil; Resistance; Thymidylate synthase; Colorectal cancer; EXPRESSION PROFILE; CELLS; CHEMOSENSITIVITY; IDENTIFICATION; CHEMOTHERAPY; SENSITIVITY;
D O I
10.1007/s12094-015-1318-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The response rate of first-line fluoropyrimidine-based regimens for metastatic colorectal cancer (mCRC) is generally less than 50 %. The down-regulation of miR-197 in colorectal cancer cells after exposure to 5-fluorouracil might be related to the mechanism of resistance to fluoropyrimidine-based chemotherapy. So we investigated the regulatory mechanism of miR-197 on 5-FU sensitivity. Dual luciferase reporter gene construct and dual luciferase reporter assay were used to identify the target of miR-197. TYMS expression was evaluated by immunohistochemistry staining. 5-Fu resistance of colorectal cancer cell lines was detected by MTS assay. The expression of miR-197 was detected by real time PCR. A luciferase assay and western blot analysis confirmed that miR-197 directly binds to and negatively regulates TYMS expression. Overexpressing miR-197 could increase the sensitivity of colorectal cancer cells to 5-fluorouracil (5-FU). The expression of miR-197 negatively correlated with TYMS expression in cancerous tissues from patients with stage IV colorectal cancer. miR-197 mediates the response of colorectal cancer cells to 5-FU by regulating TYMS expression.
引用
收藏
页码:876 / 883
页数:8
相关论文
共 50 条
  • [1] MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer
    Z. Sun
    N. Zhou
    Q. Han
    L. Zhao
    C. Bai
    Y. Chen
    J. Zhou
    R. C. Zhao
    Clinical and Translational Oncology, 2015, 17 : 876 - 883
  • [2] Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer
    Nita, ME
    Tominaga, O
    Tsuruo, T
    Muto, T
    HEPATO-GASTROENTEROLOGY, 1998, 45 (24) : 2117 - 2122
  • [3] Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer
    Xi, Yaguang
    Formentini, Andrea
    Nakajima, Go
    Kornmann, Marko
    Ju, Jingfang
    ONCOLOGY REPORTS, 2008, 19 (01) : 257 - 262
  • [4] Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
    Peters, GJ
    Backus, HHJ
    Freemantle, S
    van Triest, B
    Codacci-Pisanelli, G
    van der Wilt, CL
    Smid, K
    Lunec, J
    Calvert, AH
    Marsh, S
    McLeod, HL
    Bloemena, E
    Meijer, S
    Jansen, G
    van Groeningen, CJ
    Pinedo, HM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3): : 194 - 205
  • [5] MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
    Xu, Fei
    Ye, Ming-Liang
    Zhang, Yu-Peng
    Li, Wen-Jie
    Li, Meng-Ting
    Wang, Hai-Zhou
    Qiu, Xiao
    Xu, Yan
    Yin, Jin-Wen
    Hu, Qian
    Wei, Wan-Hui
    Chang, Ying
    Liu, Lan
    Zhao, Qiu
    CANCER SCIENCE, 2020, 111 (05) : 1528 - 1541
  • [6] Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
    Ulrich, CM
    Potter, JD
    BRITISH JOURNAL OF CANCER, 2002, 86 (08) : 1365 - 1365
  • [7] Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
    C M Ulrich
    J D Potter
    British Journal of Cancer, 2002, 86 : 1365 - 1365
  • [8] Studies on thymidylate synthase structure involved in the prognosis and 5-fluorouracil resistance of human colorectal cancer.
    Sanguedolce, R
    Alessandro, R
    De Leo, G
    Gullotti, L
    Sanguedolce, F
    Vultaggio, G
    Diana, G
    Cirello, B
    Rausa, L
    ANNALS OF ONCOLOGY, 2000, 11 : 57 - 57
  • [9] A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
    Iacopetta, B
    Grieu, F
    Joseph, D
    Elsaleh, H
    BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 827 - 830
  • [10] A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
    B Iacopetta
    F Grieu
    D Joseph
    H Elsaleh
    British Journal of Cancer, 2001, 85 : 827 - 830